These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 34174522)

  • 21. Rapid detection of carbapenemase-producing gram-negative bacteria directly from blood culture bottles for a reliable guided empiric therapy.
    Rezk S; Ashraf N; Heshmat H; Elsawaf G; Elsheredy A
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):140-147. PubMed ID: 38573768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
    Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
    Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased prevalence of extended spectrum beta lactamase producers in neonatal septicaemic cases at a tertiary referral hospital.
    Bhattacharjee A; Sen MR; Prakash P; Gaur A; Anupurba S
    Indian J Med Microbiol; 2008; 26(4):356-60. PubMed ID: 18974490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
    Chong Y; Yakushiji H; Ito Y; Kamimura T
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
    Hrabák J
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment options for extended-spectrum beta-lactamase-producers.
    Essack SY
    FEMS Microbiol Lett; 2000 Sep; 190(2):181-4. PubMed ID: 11034276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.
    Zhanel GG; Chung P; Adam H; Zelenitsky S; Denisuik A; Schweizer F; Lagacé-Wiens PR; Rubinstein E; Gin AS; Walkty A; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2014 Jan; 74(1):31-51. PubMed ID: 24352909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
    Pfeifer Y; Cullik A; Witte W
    Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extended spectrum beta-lactamse (ESBL)-induced antibiotics resistance in gram-negative agents: what should be watched in intensive care medicine?].
    Kola A; Gastmeier P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):573-6. PubMed ID: 12975735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia.
    Paterson DL; Henderson A; Harris PNA
    Curr Opin Infect Dis; 2020 Feb; 33(1):78-85. PubMed ID: 31834029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contribution of extended-spectrum β-lactamases to multidrug-resistant infections in children.
    Murray TS; Peaper DR
    Curr Opin Pediatr; 2015 Feb; 27(1):124-31. PubMed ID: 25565574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview.
    Gutkind GO; Di Conza J; Power P; Radice M
    Curr Pharm Des; 2013; 19(2):164-208. PubMed ID: 22894615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The rise of resistant gram-negative bacteria].
    Kuijper EJ; van Dissel JT
    Ned Tijdschr Geneeskd; 2010; 154(45):A2868. PubMed ID: 21118590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cephalosporin resistance, tolerance, and approaches to improve their activities.
    Araten AH; Brooks RS; Choi SDW; Esguerra LL; Savchyn D; Wu EJ; Leon G; Sniezek KJ; Brynildsen MP
    J Antibiot (Tokyo); 2024 Mar; 77(3):135-146. PubMed ID: 38114565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures.
    Parmeland L; Bourru T; Kyungu V; Rousseau N; Gleize M; De Beauvoir C; Pecquet M
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115428. PubMed ID: 34174522
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.